June 10, 2025

Catalyst Pharmaceuticals, Inc. (CPRX)

⚠️ No article content returned.

..

How expats lose their wealth and how to keep yours

Unlock the financial potential of expat living! Learn how to transform your overseas experience into lasting wealth with smart planning and disciplined savings...

Premier, Inc. (PINC) Stock Analysis: Exploring the Healthcare Innovator’s Stability Amidst Challenges

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare sector, is making waves with its dual-segment approach in Supply Chain Services and Performance Services. Headquartered in Charlotte, North Carolina,..

Progyny, Inc. (PGNY) Stock Analysis: A 19.48% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare plans industry, presents an intriguing investment opportunity with a potential upside of 19.48% based on current analyst ratings. With its..

Ultragenyx Pharmaceutical Inc. (RARE)

⚠️ No article content returned.

..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 53.68% Potential Upside for Investors

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the medical devices sector, is gaining attention from investors due to its promising growth trajectory and innovative product portfolio in the..

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Powerhouse with 47.36% Potential Upside

Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 47.36%. Headquartered in Shanghai, China, Zai Lab operates..

Alvotech (ALVO) Stock Analysis: Exploring a 69% Potential Upside for Biosimilar Innovator

Alvotech (NASDAQ: ALVO), a Luxembourg-based pharmaceutical company specializing in biosimilar medicines, is capturing the attention of investors with a compelling potential upside of 69.33%. Operating in the highly dynamic healthcare..

MoonLake Immunotherapeutics (MLTX): Analyst Ratings Suggest 67.97% Upside Potential for This Swiss Biotech Innovator

MoonLake Immunotherapeutics (NASDAQ: MLTX) is carving out a strong niche in the biotechnology sector, commanding attention with its innovative approaches to treating inflammatory skin and joint diseases. Founded in 2021..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 23.29% Potential Upside in the Healthcare Sector

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the competitive healthcare sector, specifically within the niche of Medicare Advantage plans targeting seniors. Headquartered in Orange, California, this innovative company has..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: 19.3% Potential Upside Amid Impressive Revenue Growth

Investors focusing on biotechnology stocks should take a closer look at PTC Therapeutics, Inc. (NASDAQ: PTCT), a company that is making significant strides in the healthcare sector. With a market..

NewAmsterdam Pharma (NAMS) Stock Analysis: Unveiling a 111.51% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a pioneering entity in the biotechnology sector, is capturing investor attention with its impressive growth trajectory and substantial upside potential. With a market capitalization..

Arrowhead Pharmaceuticals, Inc. (ARWR): A Stock with 165% Upside Potential in Biotech Innovation

Individual investors with a keen eye on the biotechnology sector may find Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) an intriguing prospect, particularly given its potential for substantial upside. With a market..

Vericel Corporation (VCEL) Stock Analysis: Explore a 35.5% Potential Upside with Strong Buy Ratings

As investors navigate the ever-evolving landscape of the biotechnology sector, Vericel Corporation (NASDAQ: VCEL) stands out with a compelling potential upside of 35.5%. This Cambridge, Massachusetts-based biopharmaceutical company specializes in..

LivaNova PLC (LIVN): Analyst Consensus Signals 33% Upside for This Medical Device Innovator

LivaNova PLC (LIVN) stands at the forefront of the medical device industry, carving out a niche with its innovative solutions for neurological and cardiac conditions. Headquartered in London, this healthcare..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 39% Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, has captured investor attention with its significant potential upside. The company, headquartered in Dublin, Ireland, is a robust..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling a 231% Potential Upside in Biotech Innovation

As the healthcare sector continues to captivate investor interest, ImmunityBio, Inc. (NASDAQ: IBRX) stands out with a market cap of $3.04 billion and a compelling 231.40% potential upside. This biotechnology..

Concentra Group Holdings (CON): Investor Outlook Reveals 26.81% Upside Potential in Healthcare Sector

Concentra Group Holdings Parent, Inc. (CON) stands as a compelling player in the healthcare sector, specifically within the medical care facilities industry. Based in Addison, Texas, the company focuses on..

Haemonetics Corporation (HAE) Investor Outlook: Assessing a 27% Potential Upside and Robust Buy Ratings

Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector specializing in medical devices, presents a compelling investment case for individual investors. With a current market capitalization of $3.44..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Potential Upside of 21.78% Ignites Investor Interest

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) has been capturing the attention of investors with its recent performance in the biotechnology sector, particularly with an enticing potential upside of 21.78%. Based in..

Search

Funds

June 10, 2025

How expats lose their wealth and how to keep yours

Unlock the financial potential of expat living! Learn how to transform your overseas experience into lasting wealth with smart planning and disciplined savings...
Search

Funds

June 10, 2025

FTSE 100

Funds